|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Investments: | ||||||||||||||||||||
| Fixed maturities, available for sale at fair value (amortized cost — $11,425 and $11,101; allowance for expected credit losses of $25 and $21) | ||||||||||||||||||||
| Fixed maturities, trading at fair value | ||||||||||||||||||||
| Equity securities, at fair value | ||||||||||||||||||||
| Investments accounted for using the equity method | ||||||||||||||||||||
| Mortgage loans | ||||||||||||||||||||
| Real estate and other investments | ||||||||||||||||||||
| Total cash and investments | ||||||||||||||||||||
| Recoverables from reinsurers | ||||||||||||||||||||
| Prepaid reinsurance premiums | ||||||||||||||||||||
| Agents’ balances and premiums receivable | ||||||||||||||||||||
| Deferred policy acquisition costs | ||||||||||||||||||||
| Assets of managed investment entities | ||||||||||||||||||||
| Other receivables | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Variable interest entity, primary beneficiary | ||||||||||||||||||||
| Total total assets | ||||||||||||||||||||
| Liabilities and Equity: | ||||||||||||||||||||
| Unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Property and casualty insurance | ||||||||||||||||||||
| Total unpaid losses and loss adjustment expenses | ||||||||||||||||||||
| Unearned premiums | ||||||||||||||||||||
| Payable to reinsurers | ||||||||||||||||||||
| Liabilities of managed investment entities | ||||||||||||||||||||
| Long-term debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Variable interest entity, primary beneficiary | ||||||||||||||||||||
| Total total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Common Stock, no par value — 200,000,000 shares authorized — 82,916,648 and 83,422,202 shares outstanding | ||||||||||||||||||||
| Capital surplus | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income (loss), net of tax | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
Loading...
